Infinity Bio, a leader in antibody reactome profiling, announces the launch of HuSIGHT-Total™, the world’s most comprehensive ...

Hepatocellular carcinoma or HCC is the most commonly observed form of liver cancer and the fourth leading cause of ...

Infinity Bio, a leader in antibody reactome profiling, announces the launch of HuSIGHT-Totaltm, the world's most comprehensive autoantibody analysis service. This new offering provides an unparalleled ...

BALTIMORE--(BUSINESS WIRE)--Infinity Bio, a leader in antibody reactome profiling, announces the launch of HuSIGHT-Total™, the world’s most comprehensive autoantibody analysis service. This new ...

The study, which will serve "as a guide for rapid diagnosis", provides valuable information for the medical community, in ...

Unfortunately, the diagnostic and prognostic use of thyroid autoantibody measurements is hampered by technical problems as discussed below. Although autoantibody tests have inherent clinical ...

Significant associations were found between certain autoantibodies and neuropsychiatric manifestations of SLE.

Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell ...

This subclass of AIH is based solely on the autoantibody profile and clinically resembles AIH type 1. [6] ...

Tremfya is now approved for the treatment of plaque psoriasis, active psoriatic arthritis and ulcerative colitis.

Johnson & Johnson (NYSE: JNJ) has announced the FDA‘s approval of TREMFYA® (guselkumab) for adults with moderately to ...